Redmile Group, LLC G1 Therapeutics, Inc. Transaction History

Redmile Group, LLC

  • $1.28 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$9.07 - $26.32 $5.57 Million - $16.2 Million
-613,734 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$20.54 - $31.0 $4.58 Million - $6.91 Million
222,800 Added 56.99%
613,734 $16.2 Million
Q3 2019

Nov 14, 2019
BUY
$22.78 - $40.58 $2.24 Million - $3.98 Million
98,200 Added 33.55%
390,934 $8.91 Million
Q2 2019

Aug 14, 2019
BUY
$16.03 - $31.1 $4.69 Million - $9.1 Million
292,734 New
292,734 $8.98 Million

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email